Published in Lab Law Weekly, September 7th, 2007
"Novelos is in a pivotal Phase 3 lung cancer trial, which is on track for full enrollment in March 2008. We have Phase 2s in other cancer indications, having recently announced encouraging results in an ongoing ovarian cancer trial," said Harry Palmin, President and CEO of Novelos. "This purchase reinforces my continued confidence in Novelos and our prospects."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.